Haleon plc (HLN)
NYSE: HLN · Real-Time Price · USD
10.00
+0.12 (1.21%)
Apr 8, 2026, 9:42 AM EDT - Market open
Haleon Market Cap
Haleon has a market cap or net worth of $43.63 billion as of April 8, 2026. Its market cap has decreased by -2.98% in one year.
Market Cap
43.63B
Enterprise Value
53.36B
1-Year Change
-2.98%
Ranking
Category
Stock Price
$10.00
Market Cap Chart
Since July 18, 2022, Haleon's market cap has increased from $34.14B to $43.63B, an increase of 27.78%. That is a compound annual growth rate of 6.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 7, 2026 | 43.63B | -2.89% |
| Dec 31, 2025 | 44.93B | 5.03% |
| Dec 31, 2024 | 42.77B | 13.06% |
| Dec 29, 2023 | 37.83B | 3.87% |
| Dec 30, 2022 | 36.42B | 6.67% |
| Jul 18, 2022 | 34.14B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Takeda Pharmaceutical Company | 57.44B |
| Zoetis | 49.79B |
| Teva Pharmaceutical Industries | 35.03B |
| United Therapeutics | 24.75B |
| Viatris | 15.47B |
| Regencell Bioscience Holdings | 15.23B |
| Neurocrine Biosciences | 13.21B |
| Elanco Animal Health | 11.47B |